SGLT2 Inhibitor Dapagliflozin Attenuates Cardiomyocyte Injury and Inflammation Induced by PI3Kα-Selective Inhibitor Alpelisib and Fulvestrant Under Hyperglycemia.
- DOI
- 10.3390/ijms27083597
- Published
- 2026 Apr 17
- Container
- International journal of molecular sciences
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/ijms27083597,
title = {SGLT2 Inhibitor Dapagliflozin Attenuates Cardiomyocyte Injury and Inflammation Induced by PI3Kα-Selective Inhibitor Alpelisib and Fulvestrant Under Hyperglycemia.},
author = {Quagliariello V and Berretta M and Barbato M and Maurea F and Canale ML and Paccone A and Bisceglia I and Tedeschi A and Scherillo M and Santagata J and Oliva S and Dessalvi CC and Forte P and D'Ambrosio C and Matola TD and Parmentola R and Gabrielli D and Maurea N},
year = {2026},
journal = {International journal of molecular sciences},
doi = {10.3390/ijms27083597},
url = {https://doi.org/10.3390/ijms27083597}
}RIS
TY - JOUR TI - SGLT2 Inhibitor Dapagliflozin Attenuates Cardiomyocyte Injury and Inflammation Induced by PI3Kα-Selective Inhibitor Alpelisib and Fulvestrant Under Hyperglycemia. AU - Quagliariello V AU - Berretta M AU - Barbato M AU - Maurea F AU - Canale ML AU - Paccone A AU - Bisceglia I AU - Tedeschi A AU - Scherillo M AU - Santagata J AU - Oliva S AU - Dessalvi CC AU - Forte P AU - D'Ambrosio C AU - Matola TD AU - Parmentola R AU - Gabrielli D AU - Maurea N PY - 2026 JO - International journal of molecular sciences DO - 10.3390/ijms27083597 UR - https://doi.org/10.3390/ijms27083597 ER -
APA
V, Q., M, B., M, B., F, M., ML, C., A, P., I, B., A, T., M, S., J, S., S, O., CC, D., P, F., C, D., TD, M., R, P., D, G., & N, M. (2026). SGLT2 Inhibitor Dapagliflozin Attenuates Cardiomyocyte Injury and Inflammation Induced by PI3Kα-Selective Inhibitor Alpelisib and Fulvestrant Under Hyperglycemia.. International journal of molecular sciences. https://doi.org/10.3390/ijms27083597
Source records
- pubmed · retrieved 2026-09-26T17:41:14.752Z